Table 1. Continued
Topic Article Citation Article Type
The Warburg effect
Liberti, M.V. & Locasale, J.W. (2016). The Warburg effect: how does it
benefit cancer cells? Trends in Biochemical Sciences, 41, 211–218.
Zhao, Y., Butler, E.B. & Tan, M. (2013). Targeting cellular metabolism to
improve cancer therapeutics. Cell Death & Disease, 4, e532.
University of Texas at Austin (2018). Keeping cancer out of breath blocks
drug resistance. ScienceDaily, August 23. https://www.sciencedaily.com/
Sharma, A., Lee, M.-G., Shi, H., Won, M., Arambula, J. F., Sessler, J. L., et al.
(2018). Overcoming drug resistance by targeting cancer bioenergetics
with an activatable prodrug. Chem, 10, 2370–2383.
Faubert, B., Boily, G., Izreig, S., Griss, T., Samborska, B., Dong, Z., et al. (2013).
AMPK is a negative regulator of the Warburg effect and suppresses tumor
growth in vivo. Cell Metabolism, 17, 113–124.
Schmidt, M., Pfetzer, N., Schwab, M., Strauss, I. & Kämmerer, U. (2011).
Effects of a ketogenic diet on the quality of life in 16 patients with
advanced cancer: a pilot trial. Nutrition & Metabolism, 8, 54.
Lu, J., Chen, M., Tao, Z., Gao, S., Li, Y., Cao, Y., et al. (2017). Effects of
targeting SLC1A5 on inhibiting gastric cancer growth and tumor
development in vitro and in vivo. Oncotarget, 8, 76458–46467.
Figure 1. Assignment 1, for which students were asked to read secondary source articles and then respond each week to a WTL
prompt using a graphic organizer of their choice, before participating in peer evaluation, persuasive essay writing, and self-evaluation.